DrugsControl Media Services

News Detail

Teva to pay $225 mn to settle price fixing charges: DoJ (22-08-2023)

Washington, 21 Aug 2023: The Justice Department announced today deferred prosecution agreements resolving criminal antitrust charges against Teva Pharmaceuticals USA, Inc. and Glenmark Pharmaceuticals Inc., USA. As part of those agreements, both companies will divest a key busine......
View Details

Source : Department of Justice Press Release
teva pharmaceuticals jonathan kanter pravastatin Glenmark price fixing charges recidivism

Related News